Sat, Jul 12, 2014, 6:51 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • investormdpart2 investormdpart2 Dec 13, 2012 11:49 PM Flag

    Looking to Invest

    I think it's also worth noting that Elagolix is also being studied for uterine fibroids and I believe it was stated in an earlier conference call that Abbott would have data in the Spring but it was not known if they would release it or not. Clinicaltrials.gov has the uterine fibroids trial as completing this month with final completion in the spring.

    I have always believed that Abbott just might go ahead and take Neurocrine out if that data comes back positive. Abbott could be sitting on a potential blockbuster (especially if this pans for uterine fibroids) and the market cap is only $500M. Also, we have to keep in mind that Abbott does focus on CNS as well so the VMAT2 program could be an interesting fit.

    I've long thought this was a perfect acquisition target for Abbott...we'll see. They save a bundle in the longer term if these programs continue to look positive.

 
NBIX
14.19+0.03(+0.21%)Jul 11 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.